Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Depreciation and Depletion (2017 - 2025)

Historic Depreciation and Depletion for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $17000.0.

  • Catheter Precision's Depreciation and Depletion fell 1052.63% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $75000.0, marking a year-over-year increase of 4705.88%. This contributed to the annual value of $65000.0 for FY2024, which is 10312.5% up from last year.
  • As of Q3 2025, Catheter Precision's Depreciation and Depletion stood at $17000.0, which was down 1052.63% from $18000.0 recorded in Q2 2025.
  • In the past 5 years, Catheter Precision's Depreciation and Depletion registered a high of $400000.0 during Q1 2021, and its lowest value of $6000.0 during Q4 2023.
  • Its 5-year average for Depreciation and Depletion is $86111.1, with a median of $19500.0 in 2024.
  • As far as peak fluctuations go, Catheter Precision's Depreciation and Depletion tumbled by 9391.3% in 2023, and later soared by 23333.33% in 2024.
  • Catheter Precision's Depreciation and Depletion (Quarter) stood at $300000.0 in 2021, then crashed by 93.0% to $21000.0 in 2022, then crashed by 71.43% to $6000.0 in 2023, then skyrocketed by 233.33% to $20000.0 in 2024, then decreased by 15.0% to $17000.0 in 2025.
  • Its Depreciation and Depletion was $17000.0 in Q3 2025, compared to $18000.0 in Q2 2025 and $20000.0 in Q1 2025.